

"Pioneers in data science advancing clinical research and accelerating therapies to patients"
Cytel is the world's leading data science CRO, specialising in innovative clinical trial design and advanced analytics. Since 1987, the company has pioneered adaptive trial methodologies and developed industry-standard software to help pharmaceutical and biotech organisations design smarter trials and bring life-changing treatments to patients faster. With over 2,000 data scientists, biostatisticians, and regulatory experts across North America, Europe, and Asia, Cytel supports the entire drug development cycle. From discovery through commercialisation, the company delivers end-to-end biometrics, real-world evidence, health economics, and market access solutions that improve the probability of success.


2000
Team Members
1987
Founded
Contract Research
Sector
Hybrid
Work Environment
A future where data science transforms clinical research, enabling faster, smarter drug development that delivers safe and effective therapies to patients worldwide with unprecedented speed and certainty.
At Cytel, our mission is to unlock the power of data, empowering life science leaders to realise the full potential of therapies by shortening the drug development cycle and increasing the probability of success for better patient outcomes.